With an assembled Management Team collectively representing over 150 yearsÂ’ experience in drug discovery, development, registration and commercialization that has produced multiple registered pharmaceutical products and candidates, Genetobe Inc organizes around what are described as " Preclinical and Clinical Stage Assets" - proof of concept in preclinical in vivo models in the areas of.technology represnting Next generation CRISPR/Cas9 platform (miCas9) and the creation of translational genetic disease models for demonstrating preclinical efficacy
